Search   |   Print Page   |   Contact Us   |   Sign In   |   Join
Community Search
Forum: Valuing (And Pricing) Positive Outcomes & How it Impacts The Therapies That Patients Receive
View Registrations Tell a Friend About This EventTell a Friend

Value is an Analysis, Price is a Decision. Moving past efficacy alone, this forum explores how provider groups and payers use value in their analysis of what technologies to adopt.

When: Wed April 5, 2017
5:30-8:30 PM
Where: Regis College, Fine Arts Center
235 Wellesley St
Weston, Massachusetts  02493
United States
Contact: Bill Munger

Online registration is closed.
« Go to Upcoming Event List  

April 5 MDG Forum

Valuing (And Pricing) Positive Outcomes And How it Impacts The Therapies That Patients Receive        
Value is an analysis, price is a decision.
This forum focuses on past efficacy alone how do provider groups and payers use value to decide on what technologies to adopt. 

We'll also hear from a leading medical device manufacturing on how they develop a pricing strategy taking into account their target customer and market segment, focusing on how to create value for the customer.

Early registration fees
Member-$30, Non-member-$40, Student-$15

Wednesday April 5, 5:30 - 8:30 PM
Regis College Fine Arts Center
Weston, MA

Event Sponsors



Who Should Attend
  • Medical Device Manufacturers
  • Consultants
  • Entrepreneurs
  • Service Providers
  • Caregivers
  • Healthcare providers
Our Distinguished Panel

Michael Sherman, MD, MBA, MS
Senior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care

David Mok
Senior Director, Pricing Strategy & Analytics, DePuy Synthes

Dr. Maxwell Scott Hauser Laurans, MD, MBA
Assistant Professor of Neurosurgery; Chief and Director, Perioperative Services, Yale-New Haven Hospital

Jessica Homes, MJ
Executive Director of Reimbursement
Argenta Advisors, Inc.

Program Description

This Forum addresses what providers and payers  find compelling from a value prospective to decide between technologies for coverage and adoption.


We’ll hear from an expert at a leading medical device manufacturer on how they develop a pricing strategy – taking into account their target customer and market segment, while focusing on how to create value for the customer.


Regardless of the changing political climate, the needs for payers and providers to control cost will continue to increase the role value plays in technology adoption decisions. The speakers will address how value effects their decision-making processes.


Jessica Holmes of Argenta Advisors will moderate the session and set the stage for the increasing large role value plays in obtaining adoption and reimbursement for new medical technologies.


Dr. Richard Sherman of Harvard Pilgrim will provide insights from the payer prospective on value measurement in healthcare.


David Mok of DePuy Synthes will talk about how they use a pricing model canvas governed by a few simple rules to develop a rational pricing strategy that takes into account their target market segment, target customers, and value.


Dr. Maxwell Scott Hauser Laurans, MD, MBA, of Yale-New Haven Hospital will describe his work on the efficient delivery of health care, appropriate use of information technology, clinical trials, outcomes studies, and evaluation of new technologies and innovations in the surgical disciplines.


Immediately following the talks there will be a moderated panel discussion with the opportunity for the audience to ask the speakers questions.

Panel Bios
Jessica Homes, MJExecutive Director of Reimbursement, Argenta Advisors, Inc.

Jessica has over 20 years of experience in payer relations, government a airs, and reimbursement strategy and tactical planning. Jessica provides expertise in analyzing barriers and opportunities for market access in not only the traditional reimbursement environment of public and private health plans, but in the evolving value-based healthcare landscape (e.g., integrated networks, shared savings/ACOs and VBP/P4P programs).


She uses her bachelor’s degree in Mass Communication from the University of California at Berkeley and her work in public relations to cross-functionally align reimbursement goals with corporate sales and marketing initiatives.

Jessica earned a Master of Jurisprudence (MJ) in Health Law from Loyola University, Chicago, which she draws on for work in such areas as compliance, healthcare contracts, as well as legislative and regulatory analysis.

Michael Sherman, MD, MBA, MSSenior Vice President, Chief Medical Officer, Harvard Pilgrim Health Care
Dr. Sherman has been a leader in driving adoption of outcomes-based provider and pharmaceutical contracts.
He is responsible for Harvard Pilgrim’s medical trend management, provider engagement strategy, medical informatics, wellness and health promotion initiatives, care and disease management services, pharmacy services, NCQA accreditation and quality and utilization management programs.

Dr. Sherman serves on the faculty of Harvard Medical School’s Department of Population Medicine, as chair of the Board of Managers of the Harvard Pilgrim Health Care Institute and on the Advisory Board of the Institute for Clinical and Economic Review (ICER).

He is the current chair for AHIP’s CMO Leadership Council, comprised of chief medical officers from health plans throughout the United States.

Dr. Sherman is a frequent speaker at national and regional conferences and has lectured as part of the Harvard Business School executive education program on value measurement in healthcare.

David MokSenior Director, Pricing Strategy & Analytics, DePuy Synthes
David leads the pricing function for the orthopaedics business in a $5B+ U.S. region. He is a global price leader with over 15 years of multi-industry experience encompassing B2B and B2B2C technology companies, with a track record of transforming and elevating pricing capabilities & profits.

Previously, he served as Worldwide Director of Pricing at Johnson & Johnson’s $2B DePuy Synthes Spine business. In one year, he improved ASP erosion by 6% and delivered the highest percent gross profit in three years. David led efforts rolling out a comprehensive pricing plan as part of a $20B acquisition of Swiss medical device maker, Synthes.

David has been speaking professionally on the subject of pricing at various conferences throughout the country. He is currently teaching pricing at the University of California, Berkeley, Haas School of Business’ Center for Executive Education.

David began his career as a naval officer aboard a nuclear-power attack submarine where he conducted missions vital to the national security of the United States. He holds MBA, MS, and BS degrees.
Dr. Maxwell Scott Hauser Laurans, MD, MBA, Assistant Professor of Neurosurgery; Chief and Director, Perioperative Services, Yale-New Haven Hospital
Dr. Maxwell Scott Laurans is Clinical Chief and Executive Director of Perioperative Services for Yale - New Haven Hospital and Assistant Professor in the Department of Neurosurgery at the Yale School of Medicine. Dr. Laurans' area of clinical interest is in the minimally invasive treatment of spinal disorders and spinal tumors, including stereotactic radiosurgical treatment of spinal tumors. He is responsible for the operational, financial, and quality performance of Yale - New Haven Hospitals 83 operating rooms. He additionally chairs the Clinical Governance Committee for Yale - New Haven Health System which oversees the formulary development for clinical preference and physician preference devices and implants, managing approximately $500m in supply spend.

Dr. Laurans’ primary research focus is identifying ways in which to drive improved quality and value in health care delivery and determining practical implementation methods at Yale - New Haven Hospital. His research interests additionally include the efficient delivery of health care, appropriate use of information technology, clinical trials, outcomes studies, and evaluation of new technologies and innovations in the surgical disciplines.

Dr. Laurans was born and raised in Providence, RI and obtained his bachelor's degree in Economics at Yale University. He continued his education at the Yale School of Medicine where he received his Doctor of Medicine degree with Honors and was elected for admission into Alpha Omega Alpha (AOA). After medical school, Dr. Laurans completed his residency in Neurological Surgery at Yale. Dr. Laurans also holds a MBA from the Harvard Business School.

5:30-6:15PM Arrival, Networking & Dinner
6:15-6:30PM Announcements and Introductions
6:30-8:00PM Speakers and Q&A
8:00-8:30PM More networking

Program Chair

Aaron is currently the general manager of Argenta Advisors, a Massachusetts based national life science reimbursement consulting company. He has two and half years’ experience in the medical device industry. Prior to joining Argenta Aaron worked for an automated test consulting company and has spent the bulk of his professional career working with companies that help other companies bring new products to market.

Aaron joined MDG a little over two years ago as he transitioned into the medical device industry. Aaron is a member of Program Central and the Membership Committee.
He was one of the co-champions of the Diabetes Today: Discipline, Devices & Development forum held at the BU Photonic Center. He holds a BS in chemistry.

Aaron Cohen
General Manager, Argenta reSource

(Light dinner included)
Registration Fee: Early Reg.
(By Mar 29)  
Week Prior
(Mar 29 - April 5)  
At the Door
(April 5)
Members: $30 $35 $40
NonMembers: $40 $47  $55
Students with a Valid ID
$15  $15  $15 
Location (Free Parking)

Regis College, Fine Arts Center
235 Wellesley St, Weston, MA 02493
About MDG
The Medical Development Group (MDG) is a community of individuals professionally committed to the Medical Device and other Medical Technology Industry segments united by the belief that innovation and advances in technology lead to substantial improvements in health care. MDG pursues this mission through the organization of educational programs and forums: the facilitation of cross-disciplinary dialogue and collaboration; the creation of venues for networking and information sharing for current and aspiring professionals, clinicians, and entrepreneurs; and the development of alliances with complementary organizations.

more News Items
There are currently no news items posted.
more MDG Calendar

Forum: Genomics and epi-Genetics - Impact on Developments in Medicine and Society

Forum: Advanced Life Saving Pump Technologies

Networking: Medical Device Innovation - Pitch Competition

SPECIAL ALL-DAY EVENT: MEDInnovation Boston 2018

MDG Premium & Annual Sponsors


 Medical Development  Group
 POB 555
 Concord, MA 01742







 About Us
 Terms of Use
 Privacy Policy







Association Management Software Powered by YourMembership  ::  Legal